Oxidative markers and antioxidant defences in patients diagnosed with probable Alzheimer disease

Pharmacologyonline

Volumn 1, Issue , 2007, Pages 20-24

  Riverón, Gretel ^a   Cuetara E ^a   Hernandez E W ^a   Becquer P ^a   Acosta, T ^a   Marin L ^a   Pereira, N ^a   Gutierrez R ^a   Pupo, J ^a   Martinez O ^a   Pandolfi, A ^a   Cuevillas, G ^a   Llibre, J J ^a  

^a INSTITUTO SUPERIOR DE CIENCIAS MÉDICAS DE LA HABANA   (Cuba)

Author keywords

Alzheimer; Neurodegenerative diseases; Oxidative strees

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; GLUTATHIONE; MALONALDEHYDE;

AGED; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS;

EID: 34248346340     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ono K,Hamaguchi T, Naiki H, Yamada M. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease. Biochim Biophys Acta 2006; 1762, 575-586.
2. Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease J Neurochem 2006; 96, 1-13.
3. Esterbauer H and Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 1990; 186: 407-421.
4. Witko-Sarsat V, Friedlander M, Nguyen-Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161, 2524-2530.
5. Sedlak J and Lidsay RH. Estimation of total protein bound and non-protein sulfhydryl group in tissue with Ellman's reagent. Anal Biochem 1968; 25, 192-205.
6. Marklund S, Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
7. George Perry, Marta A. Taddeo, Akihiko Nunomura, Xiongwei Zhu, Tania Zenteno Savin, Kelly L. Drew, Shun Shimohama,Jesus Avila, Rudolph J. Castellani, Mark A. Smith.Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. Comparative Biochem Physiol 2002; Part C 133: 507-513.
8. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998; 150: 40-44.
9. Barnham K, Masters C, Bush A. Neurodegenerative diseases and oxidative stress. Nature 2004; 3:205-212.
10. Galbusera C, Facheris M, Magni F, Galimberti G, Sala G, Tremolada L, Isella V, Guerini FR, Appollonio I, Galli-Kienle M, Ferrarese C. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr Alzheimer Res 2004; 1:103-109.
11. Kawamoto EM, Munhoz CD, Glezer I, Bahia VS, Caramelli P, Nitrini R, Gorjao R, Curi R, Scavone C, Marcourakis T. Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol Aging 2005; 26:857-864.
12. Migliore L, Fontana I, Colognato R, Coppede F, Siciliano G, Murri L Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiology of Aging 2005; 26:587-595
13. Rinaldi P, Polidori MC,Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003; 24:915-919.
14. Benzi G, Moretti A. Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Rad Biol Med 1995; 19:77-101.
15. Wu G, Fang YZ, Yang S, Lupton JR, and Turner ND. Glutathione metabolism and its implications for health. J. Nutr. 2004; 134:489-492.
16. Zemlan FP, Thienhaus OJ & Bosmann HB. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res 1989; 476: 160-162.
17. Villa RF, Gorini A. Effect of CDP-choline treatment on mitochondrial and synaptosomal protein composition in different brain regions during aging. Int J Dev Neurosci 1993; 11:83-93.
18. Mo JQ, Hom DG, Andersen JK. Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech Ag Dev 1995; 81:73-82.